₹266.8
▼ -2.04 -0.76%
As of 23 Oct 2026 · delayed
NSE Listed
Health X Platform Limited (HEALTHX)
Volume: 7,885Avg Vol 1W: 4,049.4Avg Vol 1M: 8,249.9552W Range:₹252.5₹363
Key Ratios
Checked 13h agoMarket Cap₹849 Cr
Current Price₹266.8
Previous Close₹268.84
High / Low (52w)₹363 / ₹252.5
Volume7,885
Avg Vol (1W)4,049.4
Avg Vol (1M)8,249.95
Stock P/E505.33
Book Value₹201.47
Dividend Yield0%
ROE29.9%
ROA-278.4%
Revenue (TTM)₹1,378 Cr
Revenue Growth—
Profit Margin-137.6%
Total Debt—
Shares Outstanding3 Cr
Face Value₹10
EPS (TTM)₹0
P/B1.3
Debt / Equity0.02
50 DMA₹291.78
200 DMA₹295.39
Day change-0.76%
Price Chart
₹266.8▼ 11.68% · 1Y
2025-10-272026-10-23
20-day avg volume: 8K shares
Pros
- Healthy return on equity of 29.9%.
- Company is almost debt-free.
Cons
- Revenue fell 43% YoY.
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 505.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Profit | ₹-109 Cr | ₹-27 Cr | ₹14 Cr | ₹24 Cr | ₹-13 Cr | ₹1 Cr | ₹-11 Cr | ₹3 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,171 Cr | — | — | — | — | — | ₹1,378 Cr | — |
| EBITDA | ₹-2 Cr | — | — | — | — | — | ₹-1 Cr | — |
| Net Profit | ₹-91 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹-1 Cr |
| EPS | -28.66 | — | — | — | — | — | 0.37 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹230 Cr | ₹316 Cr | ₹293 Cr | ₹1,278 Cr | ₹1,206 Cr | ₹1,150 Cr | ₹974 Cr | ₹936 Cr |
| Total Liabilities | ₹30 Cr | ₹69 Cr | ₹63 Cr | ₹184 Cr | ₹212 Cr | ₹150 Cr | ₹110 Cr | ₹171 Cr |
| Equity | ₹200 Cr | ₹246 Cr | ₹229 Cr | ₹1,094 Cr | ₹994 Cr | ₹1,000 Cr | ₹865 Cr | ₹765 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹-30 Cr | ₹-70 Cr | ₹-30 Cr | ₹-94 Cr | ₹-116 Cr | ₹42 Cr | ₹-13 Cr | ₹-69 Cr |
| Investing | ₹-2 Cr | ₹-22 Cr | ₹21 Cr | ₹220 Cr | ₹133 Cr | ₹-34 Cr | ₹-1 Cr | ₹171 Cr |
| Financing | ₹26 Cr | ₹103 Cr | ₹4 Cr | ₹-11 Cr | ₹-2 Cr | ₹-2 Cr | ₹0 Cr | ₹-80 Cr |
| Free Cash Flow | ₹-30 Cr | ₹-70 Cr | ₹-29 Cr | ₹-94 Cr | ₹-116 Cr | ₹42 Cr | ₹-13 Cr | ₹-69 Cr |
Shareholding
Promoter 74.07% Institutions 4.94% Public 21%
Efficiency & Working Capital
ROCE-0.1%
Interest Coverage0.2
Dividend Payout—
Debtor Days2 d
Inventory Days40 d
Payable Days24 d
Cash Conversion Cycle18 d
Working Capital Days42 d
Shareholding Details
As of 2026-09-30
Promoter74.1%
FII2.3%
DII2.6%
Institutions4.9%
Public21%
Promoter Pledge0%
No. of Shareholders11,181
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.9% | 73.9% | 73.9% | 73.9% | 73.9% | 74.1% | 74.2% | 74.2% | 74.7% | 74.8% | 74.1% | 74.1% |
| FIIs | 0.5% | 0.6% | 0.6% | 1% | 1.7% | 1.6% | 1.9% | 2% | 2.2% | 2.2% | 2.3% | 2.3% |
| DIIs | 0.9% | 1% | 1.4% | 2% | 1.9% | 2.1% | 2.1% | 2.1% | 2.1% | 2.6% | 2.6% | 2.6% |
| Public | 24.7% | 24.6% | 24.1% | 23.1% | 22.5% | 22.2% | 21.8% | 21.7% | 21% | 20.4% | 21% | 21% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 14,053 | 14,544 | 14,493 | 15,360 | 14,093 | 13,693 | 13,452 | 13,012 | 12,287 | 11,845 | 11,502 | 11,181 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Banwari Lal Mittal | Shareholding of Promoter and Promoter Group | 33.9% | 1.08 Cr |
| Topview Enclaves Llp | Shareholding of Promoter and Promoter Group | 24.8% | 78,77,745 |
| Luv Kush Projects Limited | Shareholding of Promoter and Promoter Group | 12% | 38,05,234 |
| Ravi Kant Sharma | Shareholding of Promoter and Promoter Group | 2.4% | 7,47,393 |
| Lekh Raj Juneja | Public Shareholding | 1.9% | 5,99,990 |
| Magnum Health And Safety Pvt Ltd | Public Shareholding | 1.3% | 4,24,004 |
| Sanjay Agarwal, Rahul Kumar Agrawal And Pratap Singh As Trustees Of Microsec Vision Employees Trust | Public Shareholding | 1.3% | 4,08,600 |
| Airavat Capital Trust - Airavat Capital Trust Ii | Public Shareholding | 1.2% | 3,91,169 |
| Legends Global Opportunities (singapore) Pte. Ltd. | Public Shareholding | 1.2% | 3,75,034 |
| Bharati Sharma | Shareholding of Promoter and Promoter Group | 1% | 3,23,200 |
| Abha Mittal | Shareholding of Promoter and Promoter Group | 0.1% | 15,700 |
| Vidhi Mittal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Krishna Mittal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Saloni Mittal Beriwala | Shareholding of Promoter and Promoter Group | 0% | 0 |
| B L Mittal Huf (karta Banwari Lal Mittal) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sajjan Kumar Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kanta Devi Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mohit Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Stuti Sharma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Giridhari Lal Mishra | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ravi Kant Sharma Jointly With Bharati Sharma As Trustee Of Microsec Vision Trust One | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Club Kautilya Fintech Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Banwari Lal Mittal | CMD & Executive Director | 2025 |
| Ravi Kant Sharma | Non Executive Director | 2025 |
| Abha Mittal | Non Executive Director | 2025 |
| RUPANJANA DE | Independent Non Exe. Director | 2025 |
| J. N. Mukhopadhyaya | Independent Non Exe. Director | 2025 |
| Anjana Dikshit | Independent Non Exe. Director | 2025 |
| PRATAP SINGH | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Financing & Investment | ₹18 Cr | 99.8% |
| Investment Banking & Related Servic | ₹0 Cr | 0.2% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 36 | 32 | 32 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-07 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 60 | 0 | 0 | 0 | 0 | 60 |
| 2026 | 59 | 0 | 0 | 0 | 0 | 59 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
Insider / Designated-Person Trades
21 recent disclosure(s)
Ravi Kant SharmaSell · 2,50,000
Banwari Lal MittalAcquisition · 5,000
Banwari Lal MittalAcquisition · 5,000
Banwari Lal MittalAcquisition · 5,132
Banwari Lal MittalAcquisition · 7,663
Banwari Lal MittalAcquisition · 11,671
Substantial Acquisitions (SAST)
1 disclosure(s)
Market03/06/2026 · 2,50,000
Company Information
Incorporated1989
ChairmanBanwari Lal Mittal
AuditorJKVS & Co
Investor Email[email protected]; [email protected]
📍 Azimganj House 2nd Floor, 7 Abanindra Nath Thakur Sarani, Kolkata, West Bengal, 700017
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
HDFC Asset Management Company Ltd.HDFC Bank Ltd.HDFC Life Insurance Company Ltd.HD Fire Protect LimitedHousing Development & Infrastructure Ltd.Heads UP Ventures LimitedHEC Infra Projects Ltd.HeidelbergCement India Ltd.Hemisphere Properties India Ltd.Heranba Industries Ltd.Heritage Foods Ltd.Hero MotocorpAll “H” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search